HU230199B1 - A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok - Google Patents

A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok Download PDF

Info

Publication number
HU230199B1
HU230199B1 HU9900884A HUP9900884A HU230199B1 HU 230199 B1 HU230199 B1 HU 230199B1 HU 9900884 A HU9900884 A HU 9900884A HU P9900884 A HUP9900884 A HU P9900884A HU 230199 B1 HU230199 B1 HU 230199B1
Authority
HU
Hungary
Prior art keywords
cells
bacterium
infected
culture
vaccine
Prior art date
Application number
HU9900884A
Other languages
English (en)
Hungarian (hu)
Inventor
Jeffrey P Knittel
Michael B Roof
Original Assignee
Boehringer Ingelheim/Nobl Laboratories, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27041284&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU230199(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/465,337 external-priority patent/US5714375A/en
Application filed by Boehringer Ingelheim/Nobl Laboratories, Inc filed Critical Boehringer Ingelheim/Nobl Laboratories, Inc
Publication of HUP9900884A2 publication Critical patent/HUP9900884A2/hu
Publication of HUP9900884A3 publication Critical patent/HUP9900884A3/hu
Publication of HU230199B1 publication Critical patent/HU230199B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
HU9900884A 1995-06-05 1996-06-05 A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok HU230199B1 (hu)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/465,337 1995-06-05
US08/465,337 US5714375A (en) 1995-06-05 1995-06-05 Ileal symbiont intracellularis propagation in suspended host cells
US08/658,194 1996-06-04
US08/658,194 US5885823A (en) 1995-06-05 1996-06-04 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
PCT/US1996/009576 WO1996039629A1 (en) 1995-06-05 1996-06-05 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents

Publications (3)

Publication Number Publication Date
HUP9900884A2 HUP9900884A2 (hu) 1999-07-28
HUP9900884A3 HUP9900884A3 (en) 2001-01-29
HU230199B1 true HU230199B1 (hu) 2015-10-28

Family

ID=27041284

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900884A HU230199B1 (hu) 1995-06-05 1996-06-05 A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok

Country Status (23)

Country Link
US (1) US5885823A (cg-RX-API-DMAC7.html)
EP (5) EP1655607B1 (cg-RX-API-DMAC7.html)
JP (4) JP3765834B2 (cg-RX-API-DMAC7.html)
KR (4) KR100758614B1 (cg-RX-API-DMAC7.html)
AT (3) ATE289069T1 (cg-RX-API-DMAC7.html)
AU (1) AU717045B2 (cg-RX-API-DMAC7.html)
BG (1) BG64292B1 (cg-RX-API-DMAC7.html)
BR (2) BRPI9612938B8 (cg-RX-API-DMAC7.html)
CA (1) CA2222643C (cg-RX-API-DMAC7.html)
CZ (1) CZ295933B6 (cg-RX-API-DMAC7.html)
DE (5) DE69634334T2 (cg-RX-API-DMAC7.html)
DK (3) DK1403643T3 (cg-RX-API-DMAC7.html)
ES (3) ES2173055T3 (cg-RX-API-DMAC7.html)
FR (1) FR07C0071I2 (cg-RX-API-DMAC7.html)
HU (1) HU230199B1 (cg-RX-API-DMAC7.html)
LU (1) LU91405I2 (cg-RX-API-DMAC7.html)
NL (1) NL300331I2 (cg-RX-API-DMAC7.html)
NZ (1) NZ319994A (cg-RX-API-DMAC7.html)
PL (6) PL187850B1 (cg-RX-API-DMAC7.html)
PT (3) PT1645567E (cg-RX-API-DMAC7.html)
RO (1) RO118885B1 (cg-RX-API-DMAC7.html)
RU (2) RU2265849C2 (cg-RX-API-DMAC7.html)
WO (1) WO1996039629A1 (cg-RX-API-DMAC7.html)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022328B1 (en) 1995-11-30 2006-04-04 Australian Pork Limited Therapeutic and diagnostic compositions
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
BR0011292A (pt) * 1999-05-13 2002-02-26 Pfizer Prod Inc Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos
US7029683B1 (en) 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
US7052697B1 (en) * 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
CA2372102A1 (en) * 1999-05-13 2000-11-23 Australian Pork Limited Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
BR0011294A (pt) * 1999-05-13 2002-02-26 Pfizer Prod Inc Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos
NZ515363A (en) * 1999-05-13 2003-07-25 Pfizer Prod Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
US6605696B1 (en) * 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
AU9315101A (en) * 2000-09-29 2002-04-08 Univ Arizona Improved vaccines for proliferative ileitis and methods of making and using the same
AUPR138100A0 (en) 2000-11-10 2000-12-07 Agriculture Victoria Services Pty Ltd Novel therapeutic compositions for treating infection by lawsonia spp
NZ520600A (en) * 2000-11-10 2004-08-27 Agriculture Victoria Serv Pty Novel therapeutic compositions for treating infection by Lawsonia spp
ATE501258T1 (de) * 2000-12-20 2011-03-15 Intervet Int Bv Lawsonia intracellularis impfstoff
US20030087421A1 (en) * 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
JP2006501846A (ja) * 2002-10-04 2006-01-19 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ローソニア・イントラセルラリス由来の核酸およびポリペプチド配列ならびに使用方法
UA87665C2 (ru) * 2003-07-25 2009-08-10 Берингер Ингельхайм Ветмедика, Инк. Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
CA2536989A1 (en) 2003-09-12 2005-03-24 Akzo Nobel N.V. Lawsonia intracellularis subunit vaccine
WO2005056586A1 (en) * 2003-12-09 2005-06-23 Intervet International B.V Lawsonia intracellularis 26 kd subunit vaccine
JP2007537721A (ja) * 2004-01-22 2007-12-27 インターベツト・インターナシヨナル・ベー・ベー ローソニア・イントラセルラーリスのサブユニットワクチン
EP1609870A1 (en) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Method of diagnosing lawsonia intracellularis
MY146476A (en) * 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
US20060021536A1 (en) * 2004-07-30 2006-02-02 Limin Song Method for creating an absorbent article exhibiting a harmonic color scheme
KR100621882B1 (ko) * 2004-09-30 2006-09-19 건국대학교 산학협력단 돼지 증식성 회장염 감염돈에서 로소니아인트라셀룰라리스 균을 분리하는 방법
CA2586093A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating lawsonia intracellularis
US20070212373A1 (en) * 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
MY180002A (en) 2005-12-29 2020-11-19 Boehringer Ingelheim Vetmedica Inc Multivalent pcv2 immunogenic compositions and methods of producing compositions
CN101426522B (zh) 2005-12-29 2014-11-12 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
WO2008076915A2 (en) * 2006-12-15 2008-06-26 Boehringer Ingelheim Vetmedica, Inc. Treatment of pigs with pcv2 antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
JP2011500034A (ja) * 2007-10-12 2011-01-06 ファイザー・インク ロウソニア・イントラセルラリス（ｌａｗｓｏｎｉａｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）を培養する方法
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
EP2242511A4 (en) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
ES2606131T3 (es) 2009-11-09 2017-03-22 Intervet International B.V. Método para cultivar bacterias Lawsonia intracellularis en células McCoy infectadas de forma persistente
EP2938747B1 (en) 2012-12-28 2019-05-01 Boehringer Ingelheim Vetmedica GmbH Method of making a mycoplasma vaccine
CN105579060B (zh) 2013-09-25 2021-03-16 硕腾服务有限责任公司 Pcv2b趋异株疫苗组合物以及使用方法
WO2015051099A1 (en) 2013-10-02 2015-04-09 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 protein variant and virus like particles composed thereof
US10751405B2 (en) 2015-02-04 2020-08-25 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
ES2798282T3 (es) * 2015-02-04 2020-12-10 Intervet Int Bv Una vacuna para usar contra la infección asintomática por Lawsonia en un cerdo
KR20180062468A (ko) * 2016-11-18 2018-06-11 녹십자수의약품(주) 신규한 로소니아 인트라셀룰라리스 균주 및 이의 용도
EP3758740A1 (en) 2018-02-28 2021-01-06 Boehringer Ingelheim Vetmedica GmbH Method for reducing skatole and/or indole in animals
KR20230044474A (ko) 2020-07-24 2023-04-04 베링거 인겔하임 애니멀 헬스 유에스에이 인크. 조합 돼지 백신
EP4426342A1 (en) 2021-11-01 2024-09-11 Boehringer Ingelheim Vetmedica GmbH Immunogenic gel compositions
WO2024068637A1 (en) 2022-09-27 2024-04-04 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2024260953A1 (en) * 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
CN119185351B (zh) * 2024-09-25 2025-09-16 武汉轻工大学 Li0004蛋白靶点在制备抑制劳森菌感染细胞增殖的药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132597A (en) * 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) * 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
JPS5991879A (ja) * 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) * 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
US5338670A (en) * 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) * 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) * 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) * 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) * 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
WO1992007934A1 (en) * 1990-11-01 1992-05-14 Iowa State University Research Foundation, Inc. Bacterial attenuation method and vaccine
SU1768637A1 (en) * 1990-12-04 1992-10-15 Inst Virusologii Im D I Ivanov Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
CA2123222C (en) * 1991-11-15 2001-02-27 Donald A. Dearwester Gram-negative bacterial vaccines
DE4208785A1 (de) * 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis

Also Published As

Publication number Publication date
PT1403643E (pt) 2009-10-08
RU2305707C2 (ru) 2007-09-10
KR20050048651A (ko) 2005-05-24
PT1645567E (pt) 2007-11-19
JP2007151554A (ja) 2007-06-21
EP1645567B1 (en) 2007-09-12
ES2294620T3 (es) 2008-04-01
ATE441863T1 (de) 2009-09-15
JP3920300B2 (ja) 2007-05-30
EP2199795A2 (en) 2010-06-23
RO118885B1 (ro) 2003-12-30
JP3765834B2 (ja) 2006-04-12
BG64292B1 (bg) 2004-08-31
KR20060129549A (ko) 2006-12-15
DK0843818T3 (da) 2005-05-09
DE69637251T3 (de) 2016-06-02
JP2006061165A (ja) 2006-03-09
AU717045B2 (en) 2000-03-16
WO1996039629A1 (en) 1996-12-12
PT843818E (pt) 2005-04-29
FR07C0071I2 (fr) 2010-12-31
DE843818T1 (de) 2002-11-28
EP1403643B2 (en) 2018-10-03
EP1655607B1 (en) 2015-05-13
ES2294620T5 (es) 2016-03-23
PL189287B1 (pl) 2005-07-29
JPH11507225A (ja) 1999-06-29
HK1010911A1 (en) 1999-07-02
DE69638016D1 (de) 2009-10-15
JP4263212B2 (ja) 2009-05-13
CZ295933B6 (cs) 2005-12-14
EP2199795A3 (en) 2010-11-03
BR9608338B1 (pt) 2009-05-05
CA2222643C (en) 2013-08-13
KR100513481B1 (ko) 2006-01-27
EP0843818A1 (en) 1998-05-27
DK1645567T3 (da) 2007-11-26
ATE289069T1 (de) 2005-02-15
NL300331I1 (nl) 2008-03-03
MX9709464A (es) 1998-06-30
KR20050046741A (ko) 2005-05-18
EP1645567A1 (en) 2006-04-12
LU91405I2 (fr) 2008-02-21
PL189187B1 (pl) 2005-07-29
PL189286B1 (pl) 2005-07-29
DK1645567T4 (en) 2016-04-11
DK1403643T3 (da) 2010-01-04
BRPI9612938B8 (pt) 2017-09-12
CZ389997A3 (cs) 1998-07-15
ES2173055T3 (es) 2005-07-01
FR07C0071I1 (cg-RX-API-DMAC7.html) 2008-01-02
EP2199795B1 (en) 2016-03-30
BRPI9612938B1 (pt) 2010-07-27
HUP9900884A3 (en) 2001-01-29
NZ319994A (en) 2000-01-28
KR100544857B1 (ko) 2006-01-24
EP1655607A1 (en) 2006-05-10
PL189250B1 (pl) 2005-07-29
EP0843818B1 (en) 2005-02-09
EP1403643A1 (en) 2004-03-31
DE69637251T2 (de) 2008-06-12
BG102130A (bg) 1998-09-30
JP5078740B2 (ja) 2012-11-21
KR100758614B1 (ko) 2007-09-13
RU2265849C2 (ru) 2005-12-10
PL187850B1 (pl) 2004-10-29
DE122007000102I1 (de) 2008-04-17
ES2173055T1 (es) 2002-10-16
AU6262796A (en) 1996-12-24
JP2008266340A (ja) 2008-11-06
PL187849B1 (pl) 2004-10-29
EP1645567B2 (en) 2016-01-06
RU2005114739A (ru) 2006-11-20
ATE373015T1 (de) 2007-09-15
EP1403643B1 (en) 2009-09-02
DE69634334D1 (de) 2005-03-17
BR9608338A (pt) 1999-01-05
EP0843818A4 (en) 2002-02-06
PL325872A1 (en) 1998-08-17
DE69637251D1 (de) 2007-10-25
CA2222643A1 (en) 1996-12-12
ES2332587T3 (es) 2010-02-09
NL300331I2 (nl) 2008-07-01
EP0843818B2 (en) 2018-12-19
KR19990022509A (ko) 1999-03-25
US5885823A (en) 1999-03-23
HUP9900884A2 (hu) 1999-07-28
DE69634334T2 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
HU230199B1 (hu) A Lawsonia intracellularis tenyésztése, anti-Lawsonia intracellularis vakcinák és diagnosztikumok
Gast et al. Salmonella infections
Shivaprasad et al. Pullorum disease and fowl typhoid
Kohn et al. Biology and diseases of rats
Montecucco Clostridial neurotoxins: the molecular pathogenesis of tetanus and botulism
HU217105B (hu) SIRS-vakcina, és eljárás a betegség diagnosztizálására
Carniel et al. Y. enterocolitica and Y. pseudotuberculosis
Devriese et al. Streptococcus suis infections in birds
CN108441446A (zh) 一种副猪嗜血杆菌三价灭活疫苗及其生产方法和应用
Gaskin Psittacine viral diseases: a perspective
CN108135993B (zh) 用于先天性震颤的瘟病毒疫苗
JPH08188515A (ja) 組織培養物において効能のあるトキソプラズマ ゴンデイ ブラデイゾイトワクチンの生産
GB1597259A (en) Transmissible gastroenteritis vaccines
CN108179135B (zh) 大肠杆菌噬菌体Esc-COP-7及其致病性大肠杆菌增殖抑制用途
Wai et al. Occurrence of Co-Infection of Helicobacter pullorum and Campylobacter spp. in Broiler and Village (Indigenous) Chickens.
Pinheiro et al. Haemorrhagic syndrome of Altamira
Hunter et al. Campylobacter colitis in ranch mink in Ontario
KR101842667B1 (ko) 신규한 살모넬라균 특이 박테리오파지 st3 및 이를 포함하는 항균 조성물
Robinson Campylobacter infection
KR102673134B1 (ko) 박테리오파지를 포함하는 살모넬라 엔테리티디스 증식 억제용 조성물
KR100621882B1 (ko) 돼지 증식성 회장염 감염돈에서 로소니아인트라셀룰라리스 균을 분리하는 방법
Singh et al. Diseases of Animals: Diagnosis and Management
Ngo Understanding the fish pathogen flavobacterium psychrophilum diversity for the control of rainbow trout fry syndrome in the united kingdom
Kehrli Jr et al. Clinical and immunological features associated with bovine leukocyte adhesion deficiency
RU2233174C2 (ru) Вакцина культуральная инактивированная против хламидиоза крупного и мелкого рогатого скота